Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01516320 · ClinicalTrials.gov registry record · NA
Mechanisms of Diabetes Relapse After Bariatric Surgery
A NA study, sponsored by Blandine Laferrere.
- Completed
- Registry status
- NA
- Development phase
- 56
- Enrollment target
NCT01516320 is a NA study that has completed, run by Blandine Laferrere. The registered enrollment target is 56 participants.
The verdict
NCT01516320, a NA study, has completed, sponsored by Blandine Laferrere.
- COMPLETED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
Study Summary
The objective of this study is to investigate the different mechanisms by which Gastric Bypass (GBP), laparoscopic adjustable gastric banding (LAGB) and vertical sleeve gastrectomy (VSG) affect glucose control. We wish to understand the role of weight loss versus changes in gut peptides in the short and long term in morbidly obese patients with Type 2 Diabetes Mellitus after GBP, LAGB or VSG. The 2 surgical groups will be compared at 10% equivalent weight loss and at after surgery in terms of gut hormones levels, insulin secretion and glucose control.
Interventions
- PROCEDURE Roux-en-Y Gastric Bypass
- PROCEDURE Vertical Sleeve Gastrectomy
- PROCEDURE Laparoscopic adjustable gastric banding
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2009-05-13 |
| Est. Completion | 2014-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01516320
The ClinicalTrials.gov registry entry for NCT01516320 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Blandine Laferrere, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Roux-en-Y Gastric Bypass is the first listed.
NCT01516320 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01516320 about?
NCT01516320 is a clinical study titled "Mechanisms of Diabetes Relapse After Bariatric Surgery". The objective of this study is to investigate the different mechanisms by which Gastric Bypass (GBP), laparoscopic adjustable gastric banding (LAGB) and vertical sleeve gastrectomy (VSG) affect glucose control. We wish to understand the role of weight loss versus changes in gut peptides in the short...
What is the current status of trial NCT01516320?
This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2009-05-13. Estimated completion is 2014-09-01.
What interventions are being tested in trial NCT01516320?
The interventions under investigation include: Roux-en-Y Gastric Bypass (PROCEDURE), Vertical Sleeve Gastrectomy (PROCEDURE), Laparoscopic adjustable gastric banding (PROCEDURE).
Who is sponsoring clinical trial NCT01516320?
This trial is sponsored by Blandine Laferrere, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.